Related Experiment Video
Updated: Aug 19, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Abstract:
The effects of probucol on the metabolism of low density lipoprotein (LDL) and of high density lipoprotein (HDL) were studied in five hyperlipidaemic subjects. Kinetics of LDL-B protein and HDL-AI protein were determined by two-pool analysis after reinjection of 131I labelled LDL and 125I labelled HDL at the end of placebo and treatment periods. Probucol increased the fractional removal rate of LDL in four, though plasma cholesterol levels fell significantly in only three. The synthesis of HDL-AI protein fell in all and was probably responsible for the uniform reduction in plasma apo-AI levels. Thus, probucol enhances LDL-B protein removal and bile acid excretion but inhibits AI protein formation.
Related Concept Videos
Lipid Digestion
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Bioavailability: Influencing Factors

